Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Affimed (AFMD)
NASDAQ:AFMD
Affimed (AFMD) Stock Price & Analysis
619 Followers
AFMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $5.10
Previous Close$0.7
Volume83.33K
Average Volume (3M)1.24M
Market Cap
$112.88M
Enterprise Value$102.88M
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)-1.1
Beta1.29
Next Earnings
Jun 28, 2023EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding149,339,335
10 Day Avg. Volume851,432
30 Day Avg. Volume1,241,186
Standard Deviation0.34
R-Squared0.16
Alpha0.00344
Financial Highlights & Ratios
Price to Book (P/B)0.60
Price to Sales (P/S)2.15
Price to Cash Flow (P/CF)2.00
P/FCF Ratio-0.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4.67Price Target Upside511.18% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Affimed News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AFMD FAQ
What was Affimed’s price range in the past 12 months?
Affimed lowest stock price was $0.55 and its highest was $5.10 in the past 12 months.
What is Affimed’s market cap?
Currently, no data Available
When is Affimed’s upcoming earnings report date?
Affimed’s upcoming earnings report date is Jun 28, 2023 which is in 91 days.
How were Affimed’s earnings last quarter?
Affimed released its earnings results on Mar 23, 2023. The company reported -$0.239 earnings per share for the quarter, missing the consensus estimate of -$0.207 by -$0.031.
Is Affimed overvalued?
According to Wall Street analysts Affimed’s price is currently Undervalued.
Does Affimed pay dividends?
Affimed does not currently pay dividends.
What is Affimed’s EPS estimate?
Affimed’s EPS estimate is -$0.21.
How many shares outstanding does Affimed have?
Affimed has 149,339,340 shares outstanding.
What happened to Affimed’s price movement after its last earnings report?
Affimed reported an EPS of -$0.239 in its last earnings report, missing expectations of -$0.207. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Affimed?
Among the largest hedge funds holding Affimed’s share is Baker Bros Advisors LP. It holds Affimed’s shares valued at 8M.
---
Affimed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.67 (511.18% Upside)
$4.67 (511.18% Upside)
Blogger Sentiment
Bullish
AFMD Sentiment 66%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 2.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 0.2%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.18%
12-Months-Change
Fundamentals
Return on Equity
-56.68%
Trailing 12-Months
Asset Growth
-16.42%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Affimed
Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.
---
Top 5 ETFs holding AFMD
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold AFMD. The ETFs are listed according to market value of AFMD within the ETF
---
---